| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 35.91M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, QNCX returned -89.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -94.9% |
| 1 year | -89.6% |
| 5 years | -99.8% |
| All-time high | $19,260.00 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in QNCX would be worth today ›No. Quince Therapeutics, Inc. has not paid a dividend in the past 12 months.
Quince Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol QNCX.
Quince Therapeutics, Inc. is part of the Healthcare sector.
Quince Therapeutics, Inc. has a market cap of 34.51M USD, based on the latest quote.
Quince Therapeutics, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
